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To the editor
The frequency and spectrum of germ line mutations in the high-penetrance breast cancer susceptibility genes BRCA1 and BRCA2 shows considerable variation by ethnic group. Most genetic epidemiological studies of the BRCA genes have been performed among Caucasian populations [1] , with the exception of a few studies involving other ethnic groups, such as Hispanics [2] [3] [4] , Asians [5, 6] , and African Americans [7] [8] [9] . In most of these studies only the frequencies of sequence detectable BRCA mutations were reported and large genomic rearrangements including deletions and insertions of one or more exons, which account for 6-15% of all deleterious mutations in these genes have infrequently been considered [10] [11] [12] .
Most BRCA mutations are unique; however, few recurrent mutations with founder effects have been found in European, Hispanic, American and Asian populations [13] . In a recent study on Hispanic high-risk breast/ovarian cancer families of mainly Mexican descent from South California, Weitzel and colleagues reported the identification of a novel deletion of BRCA1 exons 9 through 12 using multiplex quantitative differential polymerase chain reaction (PCR) analysis. The deletion was detected in 3.8% of families negative for sequence detectable BRCA mutations [14] . The large genomic rearrangement mutation is considered deleterious as it results in loss of critical functional domains as well as premature truncation of the BRCA1 protein. Given the relatively high prevalence of the deletion in this cohort, the authors suggest to include the screening for this mutation in the genetic testing strategy in Hispanic women without sequence detectable BRCA mutations.
The spectra of recurrent sequence detectable BRCA mutations, including some with founder effects in a cohort of Hispanic breast/ovarian cancer families of predominantly Mexican descent from the United States and in a cohort from Colombia have previously been shown to differ completely, with different common mutations being identified in the two populations [2, 4] . In order to investigate, whether the novel BRCA1 founder deletion is also specific for Hispanic families of Mexican descent or whether it also occurs in other Hispanic cohorts, we screened 229 cancer Diana Torres and Muhammad U. Rashid contributed equally to this work.
families from Colombia for its presence. Moreover, we assessed whether this mutation is present in families belonging to two other ethnic groups, including 255 Asian families from Pakistan and 54 Caucasian families from Germany. A description of the families under investigation is shown in Table 1 . Among the Colombian, Pakistani and German families, 40, 146 and 54 families without sequence detectable BRCA-mutations, respectively, have been previously described [4, 5, [15] [16] [17] . The remaining families were newly recruited within an ongoing breast cancer case-control study in Colombia and a hereditary breast cancer study in Pakistan. All newly recruited families were screened for the presence of the common BRCA mutations specific for each of these ethnic groups (three founder mutations in Colombia; three founder and one recurrent mutation in Pakistan) and none were detected (unpublished data). The research study was approved by the local Ethics committees. BRCA1 del (exons 9-12) mutation analysis was performed using a 3-primer PCR assay as previously described [14] . PCR products, including both positive and negative control samples, were separated by size on 1.5% agarose gels and visualized by ethidium bromide staining. The fragment sizes were 1,145 bp for the wild type and 742 bp for the deletion mutation. The present study included 538 affected individuals from breast and/or ovarian cancer families. The mean ages of female breast cancer onset in Colombian, Pakistani and German patients were 50 years (range 23-83, n = 224), 30 years (range 19-70, n = 218) and 44 years (range 24-70, n = 54), respectively. The mean age of ovarian cancer onset was 54 years (range 34-71, n = 4) for Colombian patients and 33 years (range 22-48, n = 26) for Pakistani patients.
None of the 538 analyzed samples carried the BRCA1 del (exons 9-12) mutation (Table 1 ). This finding suggests that this mutation is not present or is present at an extremely low frequency in Hispanic families from Colombia as well as in Pakistani and German populations.
The absence of the BRCA1 del (exons 9-12) mutation in Hispanic families from Colombia shows that this mutation does not contribute to hereditary breast/ovarian cancer in this population, nor in Pakistani and German populations. Our data confirm our previous finding that the spectra of the BRCA founder mutations differ between Hispanic families of Mexican origin from the United States and families from Colombia. These findings provide further evidence that specific risk assessment strategies for the different Hispanic populations in South America and in the United States need to be developed.
